alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › managing

managing

3 studies tagged managing, dated 2008-04-03 to 2019-11-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey 2019-11-01
  2. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease 2011-07-01
  3. Treatment options in Alzheimer's disease: maximizing benefit, managing expectations 2008-04-03

Studies

3 studies carry this tag.

Date range

2008 to 2019

Top journals

  • Dementia and geriatric cognitive disorders 1
  • Drugs 1
  • Journal of the American Board of Family Medicine : JABFM 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of the American Board of Family Medicine : JABFM 2019-11-01 Biomarkers

    Despite recent setbacks, disease-modifying treatments (DMTs) for Alzheimer disease (AD) might become available within a few years.

  2. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Drugs 2011-07-01 Brain scans and imaging

    Our recent phase II proof-of-principle studies in patients with type 2 diabetes and in nonclinical models of diabetes have helped to define the pathogenetic defects in copper regulation, and have shown that they are reversible by TETA.

  3. Treatment options in Alzheimer's disease: maximizing benefit, managing expectations

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Dementia and geriatric cognitive disorders 2008-04-03 Drug development

    Alzheimer's disease (AD) is becoming an increasingly heavy burden on the society of developed countries, and physicians now face the challenge of providing efficient treatment regimens to an ever-higher number of individuals affected by the disease.

All topic tags with their study counts